Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients

Zhifu D Sun, J. Chen, J. Aakre, Randolph Stuart Marks, Yolanda Isabel Garces, R. Jiang, O. Idowu, Julie M Cunningham, Y. Liu, V. S. Pankratz, Ping Yang

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Small-cell lung cancer (SCLC) carries the worst prognosis among lung cancer diagnoses. Combined radiation and chemotherapy is the standard of care; however, treatment outcomes vary. Variability in the rate at which chemotherapy agents are metabolized and in the capacity of repairing DNA damage has been hypothesized to be partly responsible for the treatment response variation. Genes in the glutathione metabolism and DNA repair pathways were tested through tag single-nucleotide polymorphisms (SNPs) to assess their association with survival in SCLC. Patients and methods: Blood DNA from 248 patients with primary SCLC was genotyped for 419 tag SNPs from 49 genes in the glutathione and DNA repair pathways. Association analyses with patient survival were carried out at single-SNP, whole-gene, and haplotype levels after adjusting for age, gender, tumor stage, treatment modalities, and smoking history. Results: Among the 375 SNPs successfully genotyped, 21 SNPs, located on 11 genes, showed significant association with survival. Whole-gene analyses confirmed 3 of the 11 genes: GSS, ABCC2, and XRCC1. Haplotype analyses of these three genes identified haplotype combinations and genomic locations underlying the observed SNP associations. Conclusion: Genetic variations in genes involved in the glutathione and DNA repair pathways are associated with SCLC survival.

Original languageEnglish (US)
Pages (from-to)2011-2016
Number of pages6
JournalAnnals of Oncology
Volume21
Issue number10
DOIs
StatePublished - May 3 2010

Fingerprint

Small Cell Lung Carcinoma
DNA Repair
Glutathione
Single Nucleotide Polymorphism
Survival
Genes
Haplotypes
Drug Therapy
Standard of Care
DNA Damage
Lung Neoplasms
Smoking
History
Radiation
DNA
Therapeutics

Keywords

  • DNA repair
  • Glutathione
  • Polymorphism
  • Small-cell lung cancer
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients. / Sun, Zhifu D; Chen, J.; Aakre, J.; Marks, Randolph Stuart; Garces, Yolanda Isabel; Jiang, R.; Idowu, O.; Cunningham, Julie M; Liu, Y.; Pankratz, V. S.; Yang, Ping.

In: Annals of Oncology, Vol. 21, No. 10, 03.05.2010, p. 2011-2016.

Research output: Contribution to journalArticle

@article{e60cf212b51b43faabab13c198f79a52,
title = "Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients",
abstract = "Background: Small-cell lung cancer (SCLC) carries the worst prognosis among lung cancer diagnoses. Combined radiation and chemotherapy is the standard of care; however, treatment outcomes vary. Variability in the rate at which chemotherapy agents are metabolized and in the capacity of repairing DNA damage has been hypothesized to be partly responsible for the treatment response variation. Genes in the glutathione metabolism and DNA repair pathways were tested through tag single-nucleotide polymorphisms (SNPs) to assess their association with survival in SCLC. Patients and methods: Blood DNA from 248 patients with primary SCLC was genotyped for 419 tag SNPs from 49 genes in the glutathione and DNA repair pathways. Association analyses with patient survival were carried out at single-SNP, whole-gene, and haplotype levels after adjusting for age, gender, tumor stage, treatment modalities, and smoking history. Results: Among the 375 SNPs successfully genotyped, 21 SNPs, located on 11 genes, showed significant association with survival. Whole-gene analyses confirmed 3 of the 11 genes: GSS, ABCC2, and XRCC1. Haplotype analyses of these three genes identified haplotype combinations and genomic locations underlying the observed SNP associations. Conclusion: Genetic variations in genes involved in the glutathione and DNA repair pathways are associated with SCLC survival.",
keywords = "DNA repair, Glutathione, Polymorphism, Small-cell lung cancer, Survival",
author = "Sun, {Zhifu D} and J. Chen and J. Aakre and Marks, {Randolph Stuart} and Garces, {Yolanda Isabel} and R. Jiang and O. Idowu and Cunningham, {Julie M} and Y. Liu and Pankratz, {V. S.} and Ping Yang",
year = "2010",
month = "5",
day = "3",
doi = "10.1093/annonc/mdq212",
language = "English (US)",
volume = "21",
pages = "2011--2016",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients

AU - Sun, Zhifu D

AU - Chen, J.

AU - Aakre, J.

AU - Marks, Randolph Stuart

AU - Garces, Yolanda Isabel

AU - Jiang, R.

AU - Idowu, O.

AU - Cunningham, Julie M

AU - Liu, Y.

AU - Pankratz, V. S.

AU - Yang, Ping

PY - 2010/5/3

Y1 - 2010/5/3

N2 - Background: Small-cell lung cancer (SCLC) carries the worst prognosis among lung cancer diagnoses. Combined radiation and chemotherapy is the standard of care; however, treatment outcomes vary. Variability in the rate at which chemotherapy agents are metabolized and in the capacity of repairing DNA damage has been hypothesized to be partly responsible for the treatment response variation. Genes in the glutathione metabolism and DNA repair pathways were tested through tag single-nucleotide polymorphisms (SNPs) to assess their association with survival in SCLC. Patients and methods: Blood DNA from 248 patients with primary SCLC was genotyped for 419 tag SNPs from 49 genes in the glutathione and DNA repair pathways. Association analyses with patient survival were carried out at single-SNP, whole-gene, and haplotype levels after adjusting for age, gender, tumor stage, treatment modalities, and smoking history. Results: Among the 375 SNPs successfully genotyped, 21 SNPs, located on 11 genes, showed significant association with survival. Whole-gene analyses confirmed 3 of the 11 genes: GSS, ABCC2, and XRCC1. Haplotype analyses of these three genes identified haplotype combinations and genomic locations underlying the observed SNP associations. Conclusion: Genetic variations in genes involved in the glutathione and DNA repair pathways are associated with SCLC survival.

AB - Background: Small-cell lung cancer (SCLC) carries the worst prognosis among lung cancer diagnoses. Combined radiation and chemotherapy is the standard of care; however, treatment outcomes vary. Variability in the rate at which chemotherapy agents are metabolized and in the capacity of repairing DNA damage has been hypothesized to be partly responsible for the treatment response variation. Genes in the glutathione metabolism and DNA repair pathways were tested through tag single-nucleotide polymorphisms (SNPs) to assess their association with survival in SCLC. Patients and methods: Blood DNA from 248 patients with primary SCLC was genotyped for 419 tag SNPs from 49 genes in the glutathione and DNA repair pathways. Association analyses with patient survival were carried out at single-SNP, whole-gene, and haplotype levels after adjusting for age, gender, tumor stage, treatment modalities, and smoking history. Results: Among the 375 SNPs successfully genotyped, 21 SNPs, located on 11 genes, showed significant association with survival. Whole-gene analyses confirmed 3 of the 11 genes: GSS, ABCC2, and XRCC1. Haplotype analyses of these three genes identified haplotype combinations and genomic locations underlying the observed SNP associations. Conclusion: Genetic variations in genes involved in the glutathione and DNA repair pathways are associated with SCLC survival.

KW - DNA repair

KW - Glutathione

KW - Polymorphism

KW - Small-cell lung cancer

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=77957105987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957105987&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdq212

DO - 10.1093/annonc/mdq212

M3 - Article

VL - 21

SP - 2011

EP - 2016

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

ER -